Decreasing pain in prostate surgery
Phase 2
- Conditions
- Benign prostatic hyperplasia.Hyperplasia of prostate
- Registration Number
- IRCT2015061822168N2
- Lead Sponsor
- Vice chancellor for research, Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 38
Inclusion Criteria
Patients who are candidate for open prostatectomy due to obstructive urinary symptom and do not have allergy to bupivacaine
Exclusion criteria: Prostatic capsule perforation during the surgery
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of pethidine used. Timepoint: Every our in the first 8 hours from the surgery and then every 3 hours therafter up to 24 hours. Method of measurement: The amount of used drug in miligram.;Amount of pain. Timepoint: Every our in the first 8 hours from the surgery and then every 3 hours therafter up to 24 hours. Method of measurement: Based on pain visual analog scale which is filled by the patient from 0 to 10.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: 24 hours after the surgery. Method of measurement: Any changes in blood pressure and cardiac arrhythmias.